Filing
Spy
Filing
Spy
Home
About
HALO — Halozyme Therapeutics Inc - FilingSpy
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
2 holders
Ownership
Activity
2025 Q4
1 of 25 quarters
Total Value
$38.08M
Total Shares
565.9K
Net Share Change
+74.7K
Activity
2 buying
Investor
Value
Shares
Weight
Change
Bridgewater Associates LP
$37.79M
561.6K
0.1%
ADD
+74.5K
(+15.3%)
Bridgewater Associates LP
$37.79M
561.6K shares
ADD
+74.5K
(+15.3%)
Pzena Investment Management
$287.9K
4.3K
0.0%
ADD
+171
(+4.2%)
Pzena Investment Management
$287.9K
4.3K shares
ADD
+171
(+4.2%)